12-114385476-C-G
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM2PM5PP3_StrongPP5_Moderate
The NM_181486.4(TBX5):c.755G>C(p.Ser252Thr) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S252I) has been classified as Likely pathogenic.
Frequency
Consequence
NM_181486.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- Holt-Oram syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
- heart conduction diseaseInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TBX5 | NM_181486.4 | c.755G>C | p.Ser252Thr | missense_variant, splice_region_variant | Exon 7 of 9 | ENST00000405440.7 | NP_852259.1 | |
| TBX5 | NM_000192.3 | c.755G>C | p.Ser252Thr | missense_variant, splice_region_variant | Exon 7 of 9 | NP_000183.2 | ||
| TBX5 | NM_080717.4 | c.605G>C | p.Ser202Thr | missense_variant, splice_region_variant | Exon 6 of 8 | NP_542448.1 | ||
| TBX5 | XM_017019912.2 | c.803G>C | p.Ser268Thr | missense_variant, splice_region_variant | Exon 7 of 9 | XP_016875401.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TBX5 | ENST00000405440.7 | c.755G>C | p.Ser252Thr | missense_variant, splice_region_variant | Exon 7 of 9 | 1 | NM_181486.4 | ENSP00000384152.3 | ||
| TBX5 | ENST00000310346.8 | c.755G>C | p.Ser252Thr | missense_variant, splice_region_variant | Exon 7 of 9 | 1 | ENSP00000309913.4 | |||
| TBX5 | ENST00000349716.9 | c.605G>C | p.Ser202Thr | missense_variant, splice_region_variant | Exon 6 of 8 | 1 | ENSP00000337723.5 | |||
| TBX5 | ENST00000526441.1 | c.755G>C | p.Ser252Thr | missense_variant, splice_region_variant | Exon 6 of 7 | 1 | ENSP00000433292.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Holt-Oram syndrome Pathogenic:1
- -
not provided Pathogenic:1
The S252T missense variant has not been previously reported as disease causing nor as a benign polymorphism. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. S252T alters the last base of exon 7, immediately 5' of the canonical GT" splice donor site. In silico analysis with several different splice algorithms predicts that this splice donor site is abolished or altered, potentially leading to aberrant gene splicing. In addition, two other nucleotide changes (G>T aka S252I and G>A aka S252N) at this highly conserved position have been seen in multiple patients referred for clinical testing for HOS at GeneDx. Although the effect of these variants on gene splicing has not yet been demonstrated, S252I has been reported in the literature in association with Holt-Oram syndrome (Cross et al., 2000). In summary, we consider S252T to be likely pathogenic; however, the possibility that it is benign cannot be excluded." -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at